Login

Regional biotech hub in Indiana to get boost from Eli Lilly’s planned $4.5 billion investment

Pharmaceutical company's research facility adds to larger manufacturing investments in the area
A rendering of the planned $4.5 billion Lilly Medicine Foundry in Lebanon, Indiana. (Eli Lilly)
A rendering of the planned $4.5 billion Lilly Medicine Foundry in Lebanon, Indiana. (Eli Lilly)
CoStar News
October 3, 2024 | 9:12 P.M.

Eli Lilly's plans to build a multibillion-dollar drug research facility in Indiana is expected to help establish a regional biotechnology hub that strengthens the country's biotech supply chain.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In